Skip to main content
logo
Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
3.480
-0.560 (-13.86%)
Oct 19, 2026, 1:30 PM EDT - Market open

APUS Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6.9900.410.010.17
Cash & Short-Term Investments
6.9900.410.010.17
Cash Growth
26194.14%-99.16%6551.77%-96.40%-
Prepaid Expenses
2.10.010.01-0
Total Current Assets
9.090.010.420.010.17
Total Assets
9.250.010.420.010.17

Liabilities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0---0.01
Accrued Expenses
0.230.70.120.04-
Short-Term Debt
0.50.33-0.28-
Current Income Taxes Payable
---0-
Total Current Liabilities
1.091.020.120.320.01
Long-Term Debt
-0.350.270.40.4
Total Liabilities
1.091.370.390.720.41

Shareholders' Equity

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.130.080.080.10.1
Additional Paid-In Capital
17.272.952.951.411.22
Retained Earnings
-9.24-4.39-3-2.22-1.56
Shareholders' Equity
8.16-1.360.03-0.71-0.24
Total Liabilities & Equity
9.250.010.420.010.17

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.50.670.270.680.4
Net Cash (Debt)
6.49-0.670.14-0.68-0.23
Net Cash Growth
-----
Net Cash Per Share
0.67-0.080.03-0.18-0.06
Filing Date Shares Outstanding
12.588.197.95.773.85
Total Common Shares Outstanding
12.587.97.95.773.85
Working Capital
8-1.010.3-0.310.16
Book Value Per Share
0.65-0.170.00-0.12-0.06
Tangible Book Value
8.16-1.360.03-0.71-0.24
Tangible Book Value Per Share
0.65-0.170.00-0.12-0.06
SEC Filings: 10-K · 10-Q